Related references
Note: Only part of the references are listed.Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
Zin W. Myint et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Force-dependent breaching of the basement membrane
Tammy T. Chang et al.
MATRIX BIOLOGY (2017)
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
Pingting Zhou et al.
MOLECULAR CANCER (2017)
EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez-Carmona et al.
MOLECULAR ONCOLOGY (2017)
Pancreatic cancer stroma: controversies and current insights
Daniel Ansari et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Microbiome and pancreatic cancer: A comprehensive topic review of literature
Natalie Ertz-Archambault et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
A. J. Rice et al.
ONCOGENESIS (2017)
The microbiome and hepatobiliary-pancreatic cancers
Kosuke Mima et al.
CANCER LETTERS (2017)
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients
Carmine Carbone et al.
CLINICAL CANCER RESEARCH (2017)
Cancer immunotherapies targeting the PD-1 signaling pathway
Yoshiko Iwai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers
Dan Calatayud et al.
BIOMARKER RESEARCH (2017)
Tumor cell intravasation
Serena P. H. Chiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Combined inhibition of IL1, CXCR1/2, and TGF beta signaling pathways modulates in-vivo resistance to anti-VEGF treatment
Carmine Carbone et al.
ANTI-CANCER DRUGS (2016)
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Angus G. Dalgleish et al.
BRITISH JOURNAL OF CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients
Geny Piro et al.
CLINICAL CANCER RESEARCH (2016)
Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction
Sirio Dupont
EXPERIMENTAL CELL RESEARCH (2016)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
Role of immune cells in pancreatic cancer from bench to clinical application An updated review
Jae Hyuck Chang et al.
MEDICINE (2016)
Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression
Hanane Laklai et al.
NATURE MEDICINE (2016)
Meta-Analysis of EMT Datasets Reveals Different Types of EMT
Lining Liang et al.
PLOS ONE (2016)
Immune checkpoint therapy for pancreatic cancer
Henrik Johansson et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Key players in pancreatic cancer-stroma interaction: cancer-associated fibroblasts, endothelial and inflammatory cells
Michael Friberg Bruun Nielsen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGF-induced epithelial-to-mesenchymal transition
Liutao Du et al.
CANCER MEDICINE (2016)
Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic
Emmanouil Fokas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
G. Piro et al.
BRITISH JOURNAL OF CANCER (2015)
Pancreatic Cancer Metastasis: Are we being Pre-EMTed?
Srustidhar Das et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes-Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
Dung T. Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Metastatic pancreatic cancer: Is there a light at the end of the tunnel?
Vanja Vaccaro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
A Novel NHE1-Centered Signaling Cassette Drives Epidermal Growth Factor Receptor-Dependent Pancreatic Tumor Metastasis and Is a Target for Combination Therapy
Rosa Angela Cardone et al.
NEOPLASIA (2015)
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Kazuyoshi Shiga et al.
CANCERS (2015)
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi-directionally convert into cancer stem cells
Elisa Dalla Pozza et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
An Angiopoietin-like Protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis
Carmine Carbone et al.
ONCOTARGET (2015)
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
Kevin C. Soares et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Modulation of c-kit expression in pancreatic adenocarcinoma: A novel stem cell marker responsible for the progression of the disease
Abraham Amsterdam et al.
ACTA HISTOCHEMICA (2014)
Oncogenic KRAS signalling in pancreatic cancer
S. Eser et al.
BRITISH JOURNAL OF CANCER (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Microbiota, Oral Microbiome, and Pancreatic Cancer
Dominique S. Michaud et al.
CANCER JOURNAL (2014)
Role of the Microbiota in Immunity and Inflammation
Yasmine Belkaid et al.
CELL (2014)
Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease
Davide Melisi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
The RAS and YAP1 dance, who is leading?
Vincenzo Corbo et al.
EMBO JOURNAL (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
MicroRNA-200 Is Induced by Thioredoxin-interacting Protein and Regulates Zeb1 Protein Signaling and Beta Cell Apoptosis
Stephen R. Filios et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Fibroblast heterogeneity in the cancer wound
Daniel Oehlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Disrupting the Balance between Tumor Epithelia and Stroma is a Possible Therapeutic Approach for Pancreatic Cancer
Xuqi Li
MEDICAL SCIENCE MONITOR (2014)
An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren Averett Byers et al.
CLINICAL CANCER RESEARCH (2013)
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz et al.
GUT (2013)
M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
Chao-Ying Liu et al.
LABORATORY INVESTIGATION (2013)
Stem Cell Marker Nestin Is Critical for TGF-β1-Mediated Tumor Progression in Pancreatic Cancer
Huei-Ting Su et al.
MOLECULAR CANCER RESEARCH (2013)
Genetically engineered mouse models of pancreatic adenocarcinoma
Carmen Guerra et al.
MOLECULAR ONCOLOGY (2013)
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Brian E. Kadera et al.
PLOS ONE (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm
Yue Xue et al.
CANCER GENETICS (2013)
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
Anna Tamburrino et al.
FRONTIERS IN PHARMACOLOGY (2013)
Epigenetic control of epithelial-mesenchymal-transition in human cancer
Tobias Kiesslich et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
Paolo P. Provenzano et al.
CANCER CELL (2012)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT)
Giuseppe Biamonti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Pancreatic Cancer: Between Bench and Bedside
Davide Melisi et al.
CURRENT DRUG TARGETS (2012)
Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: Molecular basis for therapeutic implications
Xiangyu Kong et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
NF-κB as a target for pancreatic cancer therapy
Carmine Carbone et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis
Min Yu et al.
NATURE (2012)
Meta-Analysis of Gene Expression Signatures Defining the Epithelial to Mesenchymal Transition during Cancer Progression
Christian J. Groeger et al.
PLOS ONE (2012)
Epithelial-Mesenchymal Transition: General Principles and Pathological Relevance with Special Emphasis on the Role of Matrix Metalloproteinases
Paola Nistico et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Growth Factors in Induction of Epithelial-Mesenchymal Transition and Metastasis
Nur Akmarina B. M. Said et al.
CELLS TISSUES ORGANS (2011)
Anti-VEGF Treatment-Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype
Carmine Carbone et al.
CLINICAL CANCER RESEARCH (2011)
Emerging pathways and future targets for the molecular therapy of pancreatic cancer
Vanja Vaccaro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Gut microbiome, obesity, and metabolic dysfunction
Herbert Tilg et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
Davide Melisi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
MicroRNAs in pancreatic ductal adenocarcinoma
Jong Y. Park et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
Benjamin Toh et al.
PLOS BIOLOGY (2011)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
Zhiwei Wang et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
TGF-β-induced epithelial to mesenchymal transition
Jian Xu et al.
CELL RESEARCH (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Karl S. Peggs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma
Justin M. M. Cates et al.
PANCREAS (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
Pancreatic stellate cells and pancreatic cancer cells: An unholy alliance
Alain Vonlaufen et al.
CANCER RESEARCH (2008)
Cancer-associated stroma fibroblasts promote pancreatic tumor progression
Rosa F. Hwang et al.
CANCER RESEARCH (2008)
LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Davide Melisi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Development and characterization of gemcitabine-resistant pancreatic tumor cells
Ami N. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
K. Aigner et al.
ONCOGENE (2007)
Epithelial to mesenchymal transition: Expression of the regulators snail, slug, and twist in pancreatic cancer
Birgit Hotz et al.
CLINICAL CANCER RESEARCH (2007)
Role of tumor endothelium in CD4+CD25+ regulatory T cell infiltration of human pancreatic carcinoma
Daniel Nummer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia
Catherine Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
NF-κB as a target for cancer therapy
Davide Melisi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Src, chemoresistance and epithelial to mesenchymal transition: are they related?
Ami N. Shah et al.
ANTI-CANCER DRUGS (2007)
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
Nabeel Bardeesy et al.
GENES & DEVELOPMENT (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
The Snail genes as inducers of cell movement and survival: implications in development and cancer
A Barrallo-Gimeno et al.
DEVELOPMENT (2005)
Angiogenesis: A target for cancer therapy
G Tortora et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma
S Nakajima et al.
CLINICAL CANCER RESEARCH (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
